Preprint · CC-BY
via OpenAlex
Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers
Christopher Taveras, Alissa M. Cutrone, Emmanuella O. Ajenu, Madeeha Hassan, Alban Longchamp, Shannon N. Tessier, Korkut Uygun, Heidi Yeh
Research Square · 2025 · ▲ 1 citations
Deregulated nutrient-sensing
Disabled macroautophagy
Rapamycin / mTOR inhibition
Rat
Human
Preclinical / animal
Abstract
Abstract Normothermic machine perfusion (NMP) enables real-time liver viability assessment and therapeutic intervention during preservation. mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition), an mTORC1 inhibitor known to induce autophagy(definition) and promote cellular resilience, represents a promising candidate for mitigating ischemic injury during NMP. We developed a rat model of warm ischemia followed by NMP to evaluate whether rapamycin improves liver graft quality. Livers were subjected to 90 minutes of warm ischemia and then perfused for three hours with or without 50nM rapamycin. While no significant differences were observed in perfusate oxygen consumption, lactate clearance, or transaminase release, histological analysis revealed that rapamycin-treated livers had improved cellular architecture and reduced necrosis compared to untreated controls. These findings suggest that rapamycin may confer structural protection independent of immediate metabolic changes. This model provides a platform to further study targeted therapies during NMP and supports the potential role of mTORC1 modulation in enhancing liver graft preservation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-7340727/v1
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Taveras, C., Cutrone, A.M., Ajenu, E.O., Hassan, M., Longchamp, A., Tessier, S.N., Uygun, K., & Yeh, H. (2025). Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-7340727/v1
Vancouver
Taveras C, Cutrone AM, Ajenu EO, Hassan M, Longchamp A, Tessier SN, et al. Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers. Research Square. 2025. doi:10.21203/rs.3.rs-7340727/v1.
BibTeX
@unpublished{christopher2025Precli,
title = {Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers},
author = {Christopher Taveras and Alissa M. Cutrone and Emmanuella O. Ajenu and Madeeha Hassan and Alban Longchamp and Shannon N. Tessier and Korkut Uygun and Heidi Yeh},
journal = {Research Square},
year = {2025},
doi = {10.21203/rs.3.rs-7340727/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Critical Care Medicine 2008
Preprint · OA
Sepsis induces brain mitochondrial dysfunction
Scandinavian Journal of Medicine and Science in Sports 2011
Open access · OA
Structural, biochemical, cellular, and functional changes in skeletal muscle extracellular matrix with aging
DNA repair 2007
Preprint · OA
Changes in the level and distribution of Ku proteins during cellular senescence
Food Frontiers 2023
Open access · CC-BY
Targeting mitochondrial quality control in muscle aging: Natural dietary products as potential interventions
Calcified Tissue International 2023
Open access · CC-BY
Mitophagy Activation by Urolithin A to Target Muscle Aging
Cell Metabolism 2024
Open access · OA